[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cingulate Inc (CING)

Cingulate Inc (CING)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cingulate Inc 1901 W. 47TH PLACE KANSAS CITY KS 66205 USA

www.cingulate.com Employees: 14 P: 913-942-2300

Sector:

Medical

Description:

Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release(TM) drug delivery platform technology to build and advance a pipeline of pharmaceutical products. Cingulate Inc. is based in KANSAS CITY, Kan.

Key Statistics

Overview:

Market Capitalization, $K 75,618
Enterprise Value, $K 65,818
Shares Outstanding, K 14,542
Float, K 13,771
% Float 94.70%
Short Interest, K 1,570
Short Float 10.80%
Days to Cover 10.02
Short Volume Ratio 0.30
% of Insider Shareholders 5.30%
% of Institutional Shareholders 41.31%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -22,450 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,870 K
EBIT, $ -24,920 K
EBITDA, $ -24,350 K

Growth:

1-Year Return 40.16%
3-Year Return -96.79%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 08/13/26
Next Earnings Date 11/12/26
Earnings Per Share ttm -3.59
EPS Growth vs. Prev Qtr 52.63%
EPS Growth vs. Prev Year 58.72%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 08/09/24

CING Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -238.40%
Return-on-Assets % -128.67%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.99
Book Value/Share 1.74
Interest Coverage -1.21
60-Month Beta -0.90
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.